NSC Statement on Employers’ Role Following Full FDA Approval of Pfizer COVID-19 Vaccine - National Safety Council

NSC Statement on Employers’ Role Following Full FDA Approval of Pfizer COVID-19 Vaccine

Approval provides employers reassurance they need to advance vaccination efforts.

August 23, 2021

Itasca, IL – The National Safety Council is pleased to see the Pfizer-BioNTech COVID-19 vaccine receive full approval from the FDA and believes this action provides employers with the reassurance they need to play an essential role in advancing vaccination against COVID-19.

COVID-19 vaccines are the clearest route to ensuring worker safety and wellbeing is prioritized in the workplace. NSC recommends employers follow our guidelines to encourage vaccine uptake by incentivizing and requiring vaccines as well as sharing information about the safety of vaccines, which now includes the full FDA-approved Pfizer vaccine. 

Death from COVID-19 is preventable, and as the Delta variant fuels a surge in COVID cases largely among the unvaccinated, the evidence continues to demonstrate vaccines are proven to be safe and effective at not only slowing COVID-19 transmission, but reducing the risk of severe illness and hospitalization in individuals who do become infected despite being vaccinated. NSC calls on employers to do their part to end this pandemic and prevent death from COVID-19 by prioritizing the health and safety of their workforce.

About the National Safety Council
The National Safety Council is America’s leading nonprofit safety advocate – and has been for over 100 years. As a mission-based organization, we work to eliminate the leading causes of preventable death and injury, focusing our efforts on the workplace, roadway and impairment. We create a culture of safety to not only keep people safer at work, but also beyond the workplace so they can live their fullest lives.